Moderate Asthma (DBCOND0034141)

Identifiers

Synonyms

Moderate asthma / Moderate asthma (disorder)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Omalizumab	A monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy.	Immunoglobulin heavy constant epsilontarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02965807	Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China	No drug interventions	treatment	1 / 2	unknown_status
NCT00974675	A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma	Tralokinumab	treatment	1	terminated
NCT04796844	MANI Real-life Perspective Observatory	No drug interventions	Not Available	Not Available	recruiting
NCT02999711	Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma	Itepekimab	other	1	completed
NCT00262652	Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics	Pyruvic acid	treatment	1 / 2	terminated
NCT05735431	Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil	Esomeprazole Fluticasone Formoterol	treatment	3	not_yet_recruiting
NCT05757908	Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist	No drug interventions	other	Not Available	completed